Contraceptives Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025


#139020

282 pages

Transparency Market Research

$ 5795

In Stock

Global Contraceptives Market: Overview

The report on the contraceptive market analyzes the current and future scenario of the global market. Increase in prevalence of unintended pregnancy, advent of new low cost generics drugs and devices of contraceptives by key players, and increase in adoption and awareness for contraceptives usage in developing countries are the major drivers of the global contraceptive market.

The contraceptive market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global contraceptive market with respect to the segments based on product type, distribution channel and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises porters five forces analysis and value chain analysis to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global contraceptive market.

Global Contraceptives Market: Market Segmentation

Based on product type, the contraceptive market is segmented as contraceptives drugs and contraceptive devices. The contraceptive drug is further segmented into oral contraceptive, contraceptive injectable, and topical contraceptive patch. Oral contraceptive is further segmented into combined contraceptives and mini-pills. Contraceptive devices is segmented into male contraceptives and female contraceptives. Female contraceptive is segmented into female condoms, contraceptive diaphragms, contraceptive sponges, contraceptive vaginal rings, intrauterine devices, sub-dermal contraceptive implants, and non-surgical permanent contraception devices. The product market segments have been analyzed based on available drugs and devices, product pipeline for new contraceptives products, cost-effectiveness, and preference for contraceptive product among population. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.

Based on distribution channel, contraceptives market is segmented into hospitals pharmacy, independent pharmacy, online platform, clinics and others. The market segments have been extensively analyzed based on availability of different contraceptive products, availability of these products at different distribution channels and geographical coverage. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

Geographically, the global contraceptive market has been categorized into five major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, Russia, France, Spain, Italy, and Rest of Europe), Asia Pacific (Japan, India, China, Australia & New Zealand and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC countries and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competitive scenario in these regions.

Global Contraceptives Market: Competitive Landscape

The report also profiles major players in the global contraceptive market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report includes Merck & Co., Inc., Cipla Inc., Allergan plc, Bayer AG, HLL Lifecare Limited, Mankind Pharma, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Mithra Pharmaceuticals, Janssen Pharmaceutical Company, Reckitt Benckiser Group plc., and others.

The Global Contraceptives Market is segmented as given below:

Global Contraceptives Market, by Product

  • Contraceptive Drugs
  • Oral Contraceptives
  • Combined Contraceptives
  • Mini-pills
  • Contraceptive Injectable
  • Topical Contraceptive Patch
  • Contraceptive Devices
  • Male Contraceptive Devices
  • Female Contraceptive Devices
  • Female Condoms
  • Contraceptive Diaphragms
  • Contraceptive Sponges
  • Contraceptive Vaginal Rings
  • Intrauterine Devices
  • Sub-dermal Contraceptives Implants
  • Non-Surgical Permanent Contraception Devices

Global Contraceptives Market, by Distribution Channel

  • Hospitals Pharmacy
  • Public
  • Private
  • Independent Pharmacy
  • Online Platform
  • Clinics
  • Others

Global Contraceptive Market, by Geography

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • U.K.
  • Russia
  • Italy
  • France
  • Spain
  • Rest of Europe
  • Asia Pacific
  • Japan
  • India
  • China
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • GCC countries
  • South Africa
  • Rest of Middle East & Africa

Table of Content

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Contraceptive Market


4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Key Market Indicators
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunity
4.5. Global Contraceptive Market Analysis and Forecasts, 20152025
4.5.1. Market Revenue Projections (US$ Mn)
4.6. Contraceptive Market - Global Supply Demand Scenario
4.7. Porters Five Force Analysis
4.8. Value Chain Analysis
4.9. Market Outlook

5. Global Contraceptive Market Analysis and Forecasts, By Product
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Key Trends
5.4. Market Value Forecast By Product , 20152025
5.4.1. Contraceptive Drugs
5.4.1.1. Oral Contraceptives
5.4.1.1.1. Combined Contraceptives
5.4.1.1.2. Mini-pills
5.4.1.2. Contraceptive Injectable
5.4.1.3. Topical Contraceptive Patch
5.4.2. Contraceptive Devices
5.4.2.1. Male Contraceptive Devices
5.4.2.2. Female Contraceptive Devices
5.4.2.2.1. Female Condoms
5.4.2.2.2. Contraceptive Diaphragms
5.4.2.2.3. Contraceptive Sponges
5.4.2.2.4. Contraceptive Vaginal Rings
5.4.2.2.5. Intrauterine Devices
5.4.2.2.6. Sub-dermal Contraceptives Implants
5.4.2.2.7. Non-Surgical Permanent Contraception Devices
5.5. Market Attractiveness By Product

6. Global Contraceptive Market Analysis and Forecasts, By Distribution Channel
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Key Trends
6.4. Market Value Forecast By Distribution Channel, 20152025
6.4.1. Hospital Pharmacy
6.4.1.1. Public
6.4.1.2. Private
6.4.2. Independent Pharmacy
6.4.3. Online Platform
6.4.4. Clinics
6.4.5. Others
6.5. Market Attractiveness By Distribution Channel

7. Global Contraceptive Market Analysis and Forecasts, By Region
7.1. Key Findings
7.2. Policies and Regulations
7.3. Market Value Forecast By Region
7.3.1. North America
7.3.2. Europe
7.3.3. Asia Pacific
7.3.4. Latin America
7.3.5. Middle East and Africa
7.4. Market Attractiveness By Country/Region

8. North America Contraceptive Market Analysis and Forecast
8.1. Introduction
8.1.1. Key Findings
8.1.2. Policies and Regulations
8.1.3. Key Trends
8.2. Market Value Forecast By Product, 20152025
8.2.1. Contraceptive Drugs
8.2.1.1. Oral Contraceptives
8.2.1.1.1. Combined Contraceptives
8.2.1.1.2. Mini-pills
8.2.1.2. Contraceptive Injectable
8.2.1.3. Topical Contraceptive Patch
8.2.2. Contraceptive Devices
8.2.2.1. Male Contraceptive Devices
8.2.2.2. Female Contraceptive Devices
8.2.2.2.1. Female Condoms
8.2.2.2.2. Contraceptive Diaphragms
8.2.2.2.3. Contraceptive Sponges
8.2.2.2.4. Contraceptive Vaginal Rings
8.2.2.2.5. Intrauterine Devices
8.2.2.2.6. Sub-dermal Contraceptives Implants
8.2.2.2.7. Non-Surgical Permanent Contraception Devices
8.3. Market Value Forecast By Distribution Channel, 20152025
8.3.1. Hospital Pharmacy
8.3.1.1. Public
8.3.1.2. Private
8.3.2. Independent Pharmacy
8.3.3. Online Platform
8.3.4. Clinics
8.3.5.Others
8.4. Market Value Forecast By Country, 20152025
8.4.1. U.S.
8.4.2. Canada
8.5. Market Attractiveness Analysis
8.5.1. By Product
8.5.2. By Distribution Channel
8.5.3. By Country

9. Europe Contraceptive Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.1.2. Policies and Regulations
9.1.3. Key Trends
9.2. Market Value Forecast By Product, 20152025
9.2.1. Contraceptive Drugs
9.2.1.1. Oral Contraceptives
9.2.1.1.1. Combined Contraceptives
9.2.1.1.2. Mini-pills
9.2.1.2. Contraceptive Injectable
9.2.1.3. Topical Contraceptive Patch
9.2.2. Contraceptive Devices
9.2.2.1. Male Contraceptive Devices
9.2.2.2. Female Contraceptive Devices
9.2.2.2.1. Female Condoms
9.2.2.2.2. Contraceptive Diaphragms
9.2.2.2.3. Contraceptive Sponges
9.2.2.2.4. Contraceptive Vaginal Rings
9.2.2.2.5. Intrauterine Devices
9.2.2.2.6. Sub-dermal Contraceptives Implants
9.2.2.2.7. Non-Surgical Permanent Contraception Devices
9.3. Market Value Forecast By Distribution Channel, 20152025
9.3.1. Hospital Pharmacy
9.3.1.1. Public
9.3.1.2. Private
9.3.2. Independent Pharmacy
9.3.3. Online Platform
9.3.4. Clinics
9.3.5. Others
9.4. Market Value Forecast By Country, 20152025
9.4.1. Germany
9.4.2. France
9.4.3. U.K.
9.4.4. Spain
9.4.5. Italy
9.4.6. Russia
9.4.7. Rest of Europe
9.5. Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By Distribution Channel
9.5.4. By Country

10. Asia Pacific Contraceptive Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.1.2. Policies and Regulations
10.1.3. Key Trends
10.2. Market Value Forecast By Product, 20152025
10.2.1. Contraceptive Drugs
10.2.1.1. Oral Contraceptives
10.2.1.1.1. Combined Contraceptives
10.2.1.1.2. Mini-pills
10.2.1.2. Contraceptive Injectable
10.2.1.3. Topical Contraceptive Patch
10.2.2. Contraceptive Devices
10.2.2.1. Male Contraceptive Devices
10.2.2.2. Female Contraceptive Devices
10.2.2.2.1. Female Condoms
10.2.2.2.2. Contraceptive Diaphragms
10.2.2.2.3. Contraceptive Sponges
10.2.2.2.4. Contraceptive Vaginal Rings
10.2.2.2.5. Intrauterine Devices
10.2.2.2.6. Sub-dermal Contraceptives Implants
10.2.2.2.7. Non-Surgical Permanent Contraception Devices
10.3. Market Value Forecast By Distribution Channel, 20152025
10.3.1. Hospital Pharmacy
10.3.1.1 Public
10.3.1.2. Private
10.3.2. Independent Pharmacy
10.3.3. Online Platforms
10.3.4. Clinics
10.3.5. Others
10.4. Market Value Forecast By Country, 20152025
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. Australia & New Zealand
10.4.5. Rest of Asia Pacific
10.5. Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By Distribution Channel
10.5.3. By Country

11. Latin America Contraceptive Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.1.2. Policies and Regulations
11.1.3. Key Trends
11.2. Market Value Forecast By Product , 20152025
11.2.1. Contraceptive Drugs
11.2.1.1. Oral Contraceptives
11.2.1.1.1. Combined Contraceptives
11.2.1.1.2. Mini-pills
11.2.1.2. Contraceptive Injectable
11.2.1.3. Topical Contraceptive Patch
11.2.2. Contraceptive Devices
11.2.2.1. Male Contraceptive Devices
11.2.2.2. Female Contraceptive Devices
11.2.2.2.1. Female Condoms
11.2.2.2.2. Contraceptive Diaphragms
11.2.2.2.3. Contraceptive Sponges
11.2.2.2.4. Contraceptive Vaginal Rings
11.2.2.2.5. Intrauterine Devices
11.2.2.2.6. Sub-dermal Contraceptives Implants
11.2.2.2.7. Non-Surgical Permanent Contraception Devices
11.3. Market Value Forecast By Distribution Channel, 20152025
11.3.1. Hospital Pharmacy
11.3.1.1. Public
11.3.1.2. Private
11.3.2. Independent Pharmacy
11.3.3. Online Platforms
11.3.4. Clinics
11.3.5. Others
11.4. Market Value Forecast By Country, 20152025
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Rest of Latin America
11.5. Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By Distribution Channel
11.5.4. By Country

12. Middle East and Africa Contraceptive Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.1.2. Policies and Regulations
12.1.3. Key Trends
12.2. Market Value Forecast By Product, 20152025
12.2.1. Contraceptive Drugs
12.2.1.1. Oral Contraceptives
12.2.1.1.1. Combined Contraceptives
12.2.1.1.2. Mini-pills
12.2.1.2. Contraceptive Injectable
12.2.1.3. Topical Contraceptive Patch
12.2.2. Contraceptive Devices
12.2.2.1. Male Contraceptive Devices
12.2.2.2. Female Contraceptive Devices
12.2.2.2.1. Female Condoms
12.2.2.2.2. Contraceptive Diaphragms
12.2.2.2.3. Contraceptive Sponges
12.2.2.2.4. Contraceptive Vaginal Rings
12.2.2.2.5. Intrauterine Devices
12.2.2.2.6. Sub-dermal Contraceptives Implants
12.2.2.2.7. Non-Surgical Permanent Contraception Devices
12.3. Market Value Forecast By End User , 20152025
12.3.1. Hospital Pharmacy
12.3.1.1. Public
12.3.1.2. Private
12.3.2. Independent Pharmacy
12.3.3. Online Platform
12.3.4. Clinics
12.3.5. Others
12.4. Market Value Forecast By Country , 20152025
12.4.1. GCC Countries
12.4.2. South Africa
12.4.3. Rest of Middle East and Africa
12.5. Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By Distribution Channel
12.5.3. By Country

13. Competition Landscape
13.1. Market Player Competition Matrix (By Tier and Size of companies)
13.2. Market Share Analysis By Company (2016)
13.3. Company Profiles
13.3.1. Merck & Co., Inc.
13.4.1.1. Overview
13.4.1.2. Financials
13.4.1.3. Recent Developments
13.4.1.4. Strategy
13.3.2. Cipla Inc.
13.4.2.1. Overview
13.4.2.2. Financials
13.4.2.3. Recent Developments
13.4.2.4. Strategy
13.3.3. Allergan plc
13.4.3.1. Overview
13.4.3.2. Financials
13.4.3.3. Recent Developments
13.4.3.4. Strategy
13.3.4. Bayer AG
13.4.4.1. Overview
13.4.4.2. Financials
13.4.4.3. Recent Developments
13.4.4.4. Strategy
13.3.5. HLL Lifecare Limited
13.4.5.1. Overview
13.4.5.2. Financials
13.4.5.3. Recent Developments
13.4.5.4. Strategy
13.3.6. Mankind Pharma
13.4.6.1. Overview
13.4.6.2. Financials
13.4.6.3. Recent Developments
13.4.6.4. Strategy
13.3.7. Pfizer, Inc.
13.4.7.1. Overview
13.4.7.2. Financials
13.4.7.3. Recent Developments
13.4.7.4. Strategy
13.3.8. Teva Pharmaceutical Industries Ltd
13.4.8.1. Overview
13.4.8.2. Financials
13.4.8.3. Recent Developments
13.4.8.4. Strategy
13.3.9. Mithra Pharmaceuticals
13.4.9.1. Overview
13.4.9.2. Financials
13.4.9.3. Recent Developments
13.4.9.4. Strategy
13.3.10. Janssen Pharmaceutical Company
13.4.10.1. Overview
13.4.10.2. Financials
13.4.10.3. Recent Developments
13.4.10.4. Strategy
13.3.11. Reckitt Benckiser Group plc
13.4.11.1. Overview
13.4.11.2. Financials
13.4.11.3. Recent Developments
13.4.11.4. Strategy

Table 01: Global Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 20152025
Table 02: Global Contraceptives Marketa Size (US$ Mn) Forecast, by Contraceptive Drugs, 20152025
Table 03: Global Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 20152025
Table 04: Global Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 20152025
Table 05: Global Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 20152025
Table 06: Global Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 20152025
Table 07: Global Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 20152025
Table 08: Global Contraceptives Market Size (US$ Mn) Forecast, by Region, 20152025
Table 09: North America Contraceptives Market Size (US$ Mn) Forecast, by Country, 20152025
Table 10: North America Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 20152025
Table 11: North America Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 20152025
Table 12: North America Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 20152025
Table 13: North America Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 20152025
Table 14: North America Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 20152025
Table 15: North America Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 20152025
Table 16: North America Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 20152025
Table 17: Europe Contraceptives Market Size (US$ Mn) Forecast, by Country, 20152025
Table 18: Europe Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 20152025
Table 19: Europe Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 20152025
Table 20: Europe Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 20152025
Table 21: Europe Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 20152025
Table 22: Europe Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 20152025
Table 23: Europe Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 20152025
Table 24: Europe Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 20152025
Table 25: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Country, 20152025
Table 26: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 20152025
Table 27: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 20152025
Table 28: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 20152025
Table 29: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 20152025
Table 30: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 20152025
Table 31: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 20152025
Table 32: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 20152025
Table 33: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Country, 20152025
Table 34: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 20152025
Table 35: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 20152025
Table 36: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 20152025
Table 37: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 20152025
Table 38: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 20152025
Table 39: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 20152025
Table 40: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 20152025
Table 41: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Country, 20152025
Table 42: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 20152025
Table 43: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 20152025
Table 44: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 20152025
Table 45: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 20152025
Table 46: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 20152025
Table 47: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 20152025
Table 48: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 20152025

Figure 01: Global Contraceptives, Market Size (US$ Mn) Forecast, 20152025
Figure 02: Global Contraceptives Market Value Share, by Product (2016)
Figure 03: Global Contraceptives Market Value Share, by Distribution Channel (2016)
Figure 04: Global Contraceptives Market Value Share, by Region (2016)
Figure 05: Global Contraceptives Market Value Share, by Product Type, 2017 and 2025
Figure 06: Global Contraceptives Market Attractiveness, by Product Type, 20172025
Figure 07: Global Contraceptives Market Value Share, by Contraceptive Drugs, 2017 and 2025
Figure 08: Global Contraceptives Market Attractiveness, by Contraceptive Drugs, 20172025
Figure 09: Global Contraceptives Market Value Share, by Oral Contraceptives, 2017 and 2025
Figure 10: Global Contraceptives Market Attractiveness, by Oral Contraceptives, 20172025
Figure 11: Global Contraceptives Market Value Share, by Contraceptive Devices, 2017 and 2025
Figure 12: Global Contraceptives Market Attractiveness, by Contraceptive Devices, 20172025
Figure 13: Global Contraceptives Market Value Share, by Female Contraceptive Devices, 2017 and 2025
Figure 14: Global Contraceptives Market Attractiveness, by Female Contraceptive Devices, 20172025
Figure 15: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Contraceptive Drugs, 20152025
Figure 16: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Contraceptive Devices, 20152025
Figure 17: Global Contraceptives Market Value Share, by Distribution Channel, 2017 and 2025
Figure 18: Global Contraceptives Market Attractiveness, by Distribution Channel, 20172025
Figure 19: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospital Pharmacy, 20152025
Figure 20: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Independent Pharmacy, 20152025
Figure 21: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Online Platform, 20152025
Figure 22: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Clinic, 20152025
Figure 23: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 20152025
Figure 24: Global Contraceptives Market Value Share, by Region, 2017 and 2025
Figure 25: Global Contraceptives Market Attractiveness, by Region, 20172025
Figure 26: North America Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 20152025
Figure 27: North America Contraceptives Market Attractiveness, by Country 20172025
Figure 28: North America Contraceptive Market Value Share, by Country, 2017 and 2025
Figure 29: North America Contraceptives Market Value Share, by Product Type, 2017 and 2025
Figure 30: North America Contraceptives Market Attractiveness, by Product Type, 20172025
Figure 31: North America Contraceptives Market Value Share, by Distribution Channel, 2017 and 2025
Figure 32: North America Contraceptives Market Attractiveness, by Distribution Channel, 20172025
Figure 33: Europe Contraceptives Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 20152025
Figure 34: Europe Contraceptives Market Attractiveness, by Country, 20172025
Figure 35: Europe Contraceptive Market Value Share, by Country, 2017 and 2025
Figure 36: Europe Contraceptives Market Value Share, by Product, 2017 and 2025
Figure 37: Europe Contraceptives Market Attractiveness, by Product, 20172025
Figure 38: Europe Contraceptives Market Value Share, by Distribution Channel, 2017 and 2025
Figure 39: Europe Contraceptives Market Attractiveness, by Distribution Channel, 20172025
Figure 40: Asia Pacific Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 20152025
Figure 41: Asia Pacific Contraceptives Market Attractiveness, by Country 20172025
Figure 42: Asia Pacific Contraceptives Market Value Share, by Country, 2017 and 2025
Figure 43: Asia Pacific Contraceptives Market Value Share, by Product Type, 2017 and 2025
Figure 44: Asia Pacific Contraceptives Market Attractiveness, by Product Type, 20172025
Figure 45: Asia Pacific Contraceptives Market Value Share, by Distribution Channel, 2017 and 2025
Figure 46: Asia Pacific Contraceptives Market Attractiveness, by Distribution Channel, 20172025
Figure 47: Latin America Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 20152025
Figure 48: Latin America Contraceptives Market Attractiveness, by Country 20172025
Figure 49: Latin America Contraceptives Market Value Share, by Country, 2017 and 2025
Figure 50: Latin America Contraceptives Market Value Share, by Product Type, 2017 and 2025
Figure 51: Latin America Contraceptives Market Attractiveness, by Product Type, 20172025
Figure 52: Latin America Contraceptives Market Value Share, by Distribution Channel, 2017 and 2025
Figure 53: Latin America Contraceptives Market Attractiveness, by Distribution Channel, 20172025
Figure 54: Middle East & Africa Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 20152025
Figure 55: Middle East & Africa Contraceptives Market Attractiveness, by Country 20172025
Figure 56: Middle East & Africa Contraceptives Market Value Share, by Country, 2017 and 2025
Figure 57: Middle East & Africa Contraceptives Market Value Share, by Product Type, 2017 and 2025
Figure 58: Middle East & Africa Contraceptives Market Attractiveness, by Product Type, 20172025
Figure 59: Middle East & Africa Contraceptives Market Value Share, by Distribution Channel, 2017 and 2025
Figure 60: Middle East & Africa Contraceptives Market Attractiveness, by Distribution Channel, 20172025
Figure 61: Global Contraceptives Drugs Market Share, by Company, 2016
Figure 62: Global Contraceptives Devices Market Share, by Company, 2016